Response by Sagris et al to Letter Regarding Article, "antithrombotic Treatment in Cryptogenic Stroke Patients with Patent Foramen Ovale: Systematic Review and Meta-Analysis"

dc.creator	Sagris D., Georgiopoulos G., Ntaios G.	en
dc.date.accessioned	2023-01-31T09:52:37Z
dc.date.available	2023-01-31T09:52:37Z
dc.date.issued	2020
dc.identifier	10.1161/STROKEAHA.119.028393
dc.identifier.issn	00392499
dc.identifier.uri	http://hdl.handle.net/11615/78655
dc.description.abstract	[No abstract available]	en
dc.language.iso	en	en
dc.source	Stroke	en
dc.source.uri	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078566089&doi=10.1161%2fSTROKEAHA.119.028393&partnerID=40&md5=ae932ba0d6097fd7d4a72d77aea3b188
dc.subject	fibrinolytic agent	en
dc.subject	cerebrovascular accident	en
dc.subject	human	en
dc.subject	patent foramen ovale	en
dc.subject	transient ischemic attack	en
dc.subject	Fibrinolytic Agents	en
dc.subject	Foramen Ovale, Patent	en
dc.subject	Humans	en
dc.subject	Ischemic Attack, Transient	en
dc.subject	Stroke	en
dc.subject	Lippincott Williams and Wilkins	en
dc.title	Response by Sagris et al to Letter Regarding Article, "antithrombotic Treatment in Cryptogenic Stroke Patients with Patent Foramen Ovale: Systematic Review and Meta-Analysis"	en
dc.type	other	en

Fichier(s) constituant ce document

Fichiers	Taille	Format	Vue
Il n'y a pas de fichiers associés à ce document.